Fig. 4From: Integrative analysis of a novel super-enhancer-associated lncRNA prognostic signature and identifying LINC00945 in aggravating glioma progressionFunctional analysis of the risk signature. A GO analysis of 6 SE-lncRNAs. B KEGG analysis of 6 SE-lncRNAs. C–E GSEA showed that the high-risk group enriched EMT, E2F targets, and the inflammatory pathwayBack to article page